Sign in
8-K

Current Report

Taysha Gene Therapies, Inc. Filed Acc 0001193125-26-207633

Results of operations

  • Item 2.02 Results of operations and financial condition

From the SEC's structured data for this filing

Loading d99032d8k.htm…